Diagnosis and treatment of early pre-Type-1 diabetes utilizing glial fibrillary acidic protein

摘要

This invention relates to the treatment and diagnosis of Type-1 Diabetes (T1D); particularly to the use of glial fibrillary acidic protein (GFAP) as a mediator of the disease; and most particularly to GFAP binding proteins useful for prediabetes screening and/or staging.